Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Nashville Tennessee

Radiology Partners moving its headquarters to Nashville

“It offers proximity to many of our partners, access to top healthcare talent and a strong ecosystem for collaboration," CEO Rich Whitney, MBA, says. 

analyst computer hiring talent search staffing human resources HR

Radiologists among employers’ 5 most-requested specialists, staffing firm says

Hiring managers made 76 requests for rads with AMN Healthcare in 2024-25, up nearly 25% from the 61 seen the previous year. 

Thumbnail

UnitedHealthcare commits to covering 1st diagnostic breast imaging exam

Beginning on Jan. 1, the country's largest private insurer will cover the initial follow-up breast exam for beneficiaries with certain plans. 

National Institutes of Health NIH

NIH violated federal law in withholding $8B grant funding, watchdog says

The Government Accountability Office wrote in a new report that the National Institutes of Health violated the Impoundment Control Act, which bars delays in allocating funds approved by Congress, when it pulled funds for research grants linked to “equity-related” initiatives.

Thumbnail

Insurance companies deny rare disease drugs to 54% of patients, survey finds

Patients told the PAN Foundation they were helped by charities and manufacturer rebate programs, with some advised by alternative funding programs to get their drugs from outside the country.

artificial intelligence heart AI

AI company raises $55M with help from leading health systems

Ultromics plans to use the new funds to help expand its presence throughout the United States. In addition, the company is focused on developing additional AI-enabled software offerings.

Karen Joynt Maddox discusses macroeconomic factors pressuring traditional models of cardiac care.

How economic forces are reshaping the future of cardiac care

Karen Joynt Maddox, MD, MPH, explained the many ways cardiology's business models are starting to evolve. She also touched on a number of other topics, including AI and the power of prevention.

Boston Scientific’s Agent Drug-Coated Balloon (DCB), which delivers a therapeutic dose of the anti-proliferative drug paclitaxel to the patient’s scar tissue to prevent ISR from recurring, gained FDA approval on March 1..

Boston Scientific’s coronary DCB gains new Medicare reimbursement

The first coronary DCB to gain FDA approval just received an additional reimbursement that could improve patient access.